Companies / Benitec Biopharma Inc.

Benitec Biopharma Inc.

Nasdaq: BNTCCIK 1808898HAYWARD, CA

Financials · FY2021

Revenue$59.0K
Net income$-37.92M
Total debt—
Cash$184.76M
Diluted EPS$-1.05
Shares outstanding34.4M

Ownership

34.4M shares outstanding · as of May 4, 2026
0.15%Insiders
Ownership
Insiders0.15%52,097
10%+ / strategic10.92%3,751,709
Institutions87.87%30,188,718
Public float1.05%361,810

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 2

View all →
Insider% of sharesShares
Buchi J KevinDirector
0.15%52,097
Mates SharonDirector
——

Institutional holders 76

View all →
HolderValue% of shares
Suvretta Capital Management, LLC$155.56M33.62%
Janus Henderson Group PLC$30.72M8.37%
Franklin Resources, Inc.$29.60M6.40%
Adage Capital Partners Gp, L.L.C.$22.59M6.17%
RA Capital Management, L.P.$19.70M5.39%
BlackRock, Inc.$18.83M4.10%
Vanguard Group Inc$15.82M3.42%
Nantahala Capital Management, LLC$13.99M3.02%
Infinitum Asset Management, LLC$12.11M2.62%
Siren, L.L.C.$10.44M2.26%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 29, 2026Buchi J Kevin
Director
GiftCommon Stock$0-52K
-49.86%
52,097
0.15% of shares
low
Jan 22, 2026Mates Sharon
Director
GrantOptions (right to buy)—+32K
31,500
0.09% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Franklin Resources, Inc.Passive13G/A—3,751,709—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
BNTCCommon StockEquity08205P209BBG00R712L56